S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Idexx Laboratories Shares Rally Following Upbeat Quarterly Results

Shares of Idexx Laboratories surged 18% to $651.88 on Monday, as the pet-healthcare firm surpassed Wall Street expectations with a strong third-quarter performance and an upward revision of its annual financial guidance.

Idexx Laboratories Shares Rally Following Upbeat Quarterly Results

The company reported a profit of $317.1 million for the quarter, rising from $274.6 million during the same period last year. Earnings reached $4.01 a share, comfortably beating the $3.73 estimate anticipated by analysts. Revenue climbed 10% to $1.21 billion, exceeding the $1.19 billion forecast.

Following these results, management raised its annual earnings outlook to a range of $14.96 to $15.16 a share, up from the previous projection of $14.69 to $14.94. Annual revenue is now expected to hit $4.74 billion to $4.77 billion, topping earlier estimates of $4.7 billion to $4.75 billion. Chief Executive Mike Erickson credited the performance to consistent commercial execution and the company's focus on innovation-driven growth.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!